These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

524 related items for PubMed ID: 10548211

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Nadroparin versus dalteparin anticoagulation in high-volume, continuous venovenous hemofiltration: a double-blind, randomized, crossover study.
    de Pont AC, Oudemans-van Straaten HM, Roozendaal KJ, Zandstra DF.
    Crit Care Med; 2000 Feb; 28(2):421-5. PubMed ID: 10708177
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Anticoagulation with prostaglandin E1 and unfractionated heparin during continuous venovenous hemofiltration.
    Kozek-Langenecker SA, Kettner SC, Oismueller C, Gonano C, Speiser W, Zimpfer M.
    Crit Care Med; 1998 Jul; 26(7):1208-12. PubMed ID: 9671370
    [Abstract] [Full Text] [Related]

  • 6. Anticoagulation with prostaglandins and unfractionated heparin during continuous venovenous haemofiltration: a randomized controlled trial.
    Kozek-Langenecker SA, Spiss CK, Gamsjäger T, Domenig C, Zimpfer M.
    Wien Klin Wochenschr; 2002 Feb 15; 114(3):96-101. PubMed ID: 12060975
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Anticoagulation with prostacyclin and heparin during continuous venovenous hemofiltration.
    Langenecker SA, Felfernig M, Werba A, Mueller CM, Chiari A, Zimpfer M.
    Crit Care Med; 1994 Nov 15; 22(11):1774-81. PubMed ID: 7956281
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A multicentre comparison of once-daily subcutaneous dalteparin (low molecular weight heparin) and continuous intravenous heparin in the treatment of deep vein thrombosis.
    Luomanmäki K, Grankvist S, Hallert C, Jauro I, Ketola K, Kim HC, Kiviniemi H, Koskivirta H, Sörskog L, Vilkko P.
    J Intern Med; 1996 Aug 15; 240(2):85-92. PubMed ID: 8810934
    [Abstract] [Full Text] [Related]

  • 12. Polyethyleneimine-treated polyacrylonitrile membrane hemofilter for critically ill patients receiving anticoagulant-free prolonged intermittent renal replacement therapy: a single-center, prospective, self-controlled pilot study.
    Su T, Jin Q, Liu Z.
    BMC Nephrol; 2017 Jun 30; 18(1):208. PubMed ID: 28666474
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Randomized Controlled Trial to Evaluate Regional Citrate Anticoagulation Plus Low-Dose of Dalteparin in Continuous Veno-Venous Hemofiltration.
    Wu B, Zhang K, Xu B, Ji D, Liu Z, Gong D.
    Blood Purif; 2015 Jun 30; 39(4):306-12. PubMed ID: 26022434
    [Abstract] [Full Text] [Related]

  • 15. Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group.
    Reeves JH, Butt WW, Shann F, Layton JE, Stewart A, Waring PM, Presneill JJ.
    Crit Care Med; 1999 Oct 30; 27(10):2096-104. PubMed ID: 10548188
    [Abstract] [Full Text] [Related]

  • 16. Continuous venovenous hemofiltration without anticoagulation.
    Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R.
    ASAIO J; 2004 Oct 30; 50(1):76-80. PubMed ID: 14763495
    [Abstract] [Full Text] [Related]

  • 17. Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.
    Zarbock A, Küllmar M, Kindgen-Milles D, Wempe C, Gerss J, Brandenburger T, Dimski T, Tyczynski B, Jahn M, Mülling N, Mehrländer M, Rosenberger P, Marx G, Simon TP, Jaschinski U, Deetjen P, Putensen C, Schewe JC, Kluge S, Jarczak D, Slowinski T, Bodenstein M, Meybohm P, Wirtz S, Moerer O, Kortgen A, Simon P, Bagshaw SM, Kellum JA, Meersch M, RICH Investigators and the Sepnet Trial Group.
    JAMA; 2020 Oct 27; 324(16):1629-1639. PubMed ID: 33095849
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial.
    Bouman CS, Oudemans-Van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J.
    Crit Care Med; 2002 Oct 27; 30(10):2205-11. PubMed ID: 12394945
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.